Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
We focus on ensuring that the "reduced" form actually stays reduced until it reaches the cells that need it most
Our team can point you to the right accessories for your peptide research setup
Visit our website or contact us to learn more about glutathione injection treatments
Research supports oral use of up to 500mg per day for up to two months as safe for healthy adults
Possible side effects Side effects can vary and may include: Injection-site irritation (redness, tenderness, swelling) Headache, fatigue, or dizziness (reported anecdotally/observationally) Digestive discomfort in some individuals Contraindications & precautions BPC-157 may not be appropriate for everyone
Athiras lead clinical candidate, fosgonimeton (formerly ATH-1017 / NDX-1017), is a structurally distinct phosphate prodrug of Dihexa not Dihexa itself
